HRT Financial
BCYC icon

HRT Financial’s Bicycle Therapeutics BCYC Stock Holding History

HRT Financial’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$280K Buy
66,237
+20,322
+44% +$93.2K ﹤0.01% 3121
2026
Q1 		$213K Buy
+45,915
New +$262K ﹤0.01% 3158
2024
Q1 		– Sell
-19,913
Closed -$360K – 2332
2023
Q4 		$360K Buy
+19,913
New +$329K ﹤0.01% 1539

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

HRT Financial's BCYC Position: Q2 2026 in Review

HRT Financial increased its Bicycle Therapeutics (BCYC) stake by 44% in Q2 2026, buying an estimated $93.2K and bringing the position to 66,237 shares worth $280K. The position accounts for ﹤0.01% of the portfolio, ranked #3121.

HRT Financial first reported a position in BCYC in Q4 2023 and has held it in 3 quarters since. The position peaked at $360K in Q4 2023. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • HRT Financial held 66,237 shares of Bicycle Therapeutics worth $280K as of Q2 2026.
  • HRT Financial bought 20,322 Bicycle Therapeutics shares in Q2 2026, an estimated $93.2K.
  • Bicycle Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3121 holding.
  • HRT Financial first reported a position in Bicycle Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • HRT Financial's Bicycle Therapeutics position peaked at $360K in Q4 2023.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.